<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(22)</volume><submitter>Sanchez-Garcia MA</submitter><pubmed_abstract>Microglia respond to Alzheimer's disease (AD) with varied transcriptional responses. We show that oligomeric Aß (oAß) induces the expression of &lt;i>Hif1a&lt;/i> and &lt;i>Egln3&lt;/i> in microglia in vitro, together with the transcription of the type I interferon signature (IFNS) genes in a PHD3-dependent manner. We identify FOXO3 as a repressor of IFNS, whose abundance decreases upon PHD3 induction in response to oAß. In vivo, loss of PHD3 correlates with abrogation of the IFNS and activation of the disease-associated microglia signature, an increase in microglia proximity to Aß plaques and phagocytosis of both Aß and small plaques. PHD3 deficiency mitigated the Aß plaque-associated neuropathology and rescued behavioral deficits of an AD mouse model. Last, we demonstrate that microglial PHD3 overex</pubmed_abstract><journal>Science advances</journal><pagination>eadu2244</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12118632</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inactivation of the PHD3-FOXO3 axis blunts the type I interferon response in microglia and ameliorates Alzheimer's disease progression.</pubmed_title><pmcid>PMC12118632</pmcid><pubmed_authors>Barba-Reyes JM</pubmed_authors><pubmed_authors>Munoz-Manchado AB</pubmed_authors><pubmed_authors>Rosales-Nieves AE</pubmed_authors><pubmed_authors>Ortega-de San Luis C</pubmed_authors><pubmed_authors>Munoz-Cabello AM</pubmed_authors><pubmed_authors>Lopez-Barneo J</pubmed_authors><pubmed_authors>Vizuete M</pubmed_authors><pubmed_authors>March-Diaz R</pubmed_authors><pubmed_authors>Heras-Garvin A</pubmed_authors><pubmed_authors>Navarro V</pubmed_authors><pubmed_authors>Mora-Romero B</pubmed_authors><pubmed_authors>Sanchez-Garcia MA</pubmed_authors><pubmed_authors>Romero-Molina C</pubmed_authors><pubmed_authors>Quinones-Canete S</pubmed_authors><pubmed_authors>Pascual A</pubmed_authors><pubmed_authors>Cokman ME</pubmed_authors><pubmed_authors>Vitorica J</pubmed_authors><pubmed_authors>Lara-Urena N</pubmed_authors><pubmed_authors>Cabello-Rivera D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inactivation of the PHD3-FOXO3 axis blunts the type I interferon response in microglia and ameliorates Alzheimer's disease progression.</name><description>Microglia respond to Alzheimer's disease (AD) with varied transcriptional responses. We show that oligomeric Aß (oAß) induces the expression of &lt;i>Hif1a&lt;/i> and &lt;i>Egln3&lt;/i> in microglia in vitro, together with the transcription of the type I interferon signature (IFNS) genes in a PHD3-dependent manner. We identify FOXO3 as a repressor of IFNS, whose abundance decreases upon PHD3 induction in response to oAß. In vivo, loss of PHD3 correlates with abrogation of the IFNS and activation of the disease-associated microglia signature, an increase in microglia proximity to Aß plaques and phagocytosis of both Aß and small plaques. PHD3 deficiency mitigated the Aß plaque-associated neuropathology and rescued behavioral deficits of an AD mouse model. Last, we demonstrate that microglial PHD3 overex</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-02T20:33:56.287Z</modification><creation>2026-05-27T03:07:58.38Z</creation></dates><accession>S-EPMC12118632</accession><cross_references><pubmed>40435260</pubmed><doi>10.1126/sciadv.adu2244</doi></cross_references></HashMap>